{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:30:50Z","timestamp":1793673050923,"version":"4.5.1"},"reference-count":42,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>The HEALing Communities Study (HCS) evaluated the effectiveness of the Communities That HEAL (CTH) intervention in preventing fatal overdoses amidst the US opioid epidemic.<\/jats:p><\/jats:sec>Objective<\/jats:title>To evaluate the impact of the CTH intervention on total drug overdose deaths and overdose deaths involving combinations of opioids with psychostimulants or benzodiazepines.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This randomized clinical trial was a parallel-arm, multisite, community-randomized, open, and waitlisted controlled comparison trial of communities in 4 US states between 2020 and 2023. Eligible communities were those reporting high opioid overdose fatality rates in Kentucky, Massachusetts, New York, and Ohio. Covariate constrained randomization stratified by state allocated communities to the intervention or control group. Trial groups were balanced by urban or rural classification, 2016-2017 fatal opioid overdose rate, and community population. Data analysis was completed by December 2023.<\/jats:p><\/jats:sec>Intervention<\/jats:title>Increased overdose education and naloxone distribution, treatment with medications for opioid use disorder, safer opioid prescribing practices, and communication campaigns to mitigate stigma and drive demand for evidence-based interventions.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The primary outcome was the number of drug overdose deaths among adults (aged 18 years or older), with secondary outcomes of overdose deaths involving specific opioid-involved drug combinations from death certificates. Rates of overdose deaths per 100\u202f000 adult community residents in intervention and control communities from July 2021 to June 2022 were compared with analyses performed in 2023.<\/jats:p><\/jats:sec>Results<\/jats:title>In 67 participating communities (34 in the intervention group, 33 in the control group) and including 8\u202f211\u202f506 participants (4\u202f251\u202f903 female [51.8%]; 1\u202f273\u202f394 Black [15.5%], 603\u202f983 Hispanic [7.4%], 5\u202f979\u202f602 White [72.8%], 354\u202f527 other [4.3%]), the average rate of overdose deaths involving all substances was 57.6 per 100\u202f000 population in the intervention group and 61.2 per 100\u202f000 population in the control group. This was not a statistically significant difference (adjusted rate ratio [aRR], 0.92; 95% CI, 0.78-1.07; P<\/jats:italic>\u2009=\u2009.26). There was a statistically significant 37% reduction (aRR, 0.63; 95% CI, 0.44-0.91; P<\/jats:italic>\u2009=\u2009.02) in death rates involving an opioid and psychostimulants (other than cocaine), and nonsignificant reductions in overdose deaths for an opioid with cocaine (6%) and an opioid with benzodiazepine (1%).<\/jats:p><\/jats:sec>Conclusion and Relevance<\/jats:title>In this clinical trial of the CTH intervention, death rates involving an opioid and noncocaine psychostimulant were reduced; total deaths did not differ statistically. Community-focused data-driven interventions that scale up evidence-based practices with communications campaigns may effectively reduce some opioid-involved polysubstance overdose deaths.<\/jats:p><\/jats:sec>Trial Registration<\/jats:title>ClinicalTrials.gov Identifier: NCT04111939<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.40006","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T15:32:55Z","timestamp":1729524775000},"page":"e2440006","source":"Crossref","is-referenced-by-count":21,"title":["Communities That HEAL Intervention and Mortality Including Polysubstance Overdose Deaths"],"prefix":"10.1001","volume":"7","author":[{"given":"Bridget","family":"Freisthler","sequence":"first","affiliation":[{"name":"Ohio State University College of Social Work, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rouba A.","family":"Chahine","sequence":"additional","affiliation":[{"name":"RTI International, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Villani","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Redonna","family":"Chandler","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Feaster","sequence":"additional","affiliation":[{"name":"University of Miami Miller School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetla","family":"Slavova","sequence":"additional","affiliation":[{"name":"University of Kentucky, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolene","family":"Defiore-Hyrmer","sequence":"additional","affiliation":[{"name":"State of Ohio Board of Pharmacy, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Y.","family":"Walley","sequence":"additional","affiliation":[{"name":"Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kosakowski","sequence":"additional","affiliation":[{"name":"Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnie","family":"Aldridge","sequence":"additional","affiliation":[{"name":"RTI International, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Barbosa","sequence":"additional","affiliation":[{"name":"RTI International, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabana","family":"Bhatta","sequence":"additional","affiliation":[{"name":"New York State Department of Health, Albany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candace","family":"Brancato","sequence":"additional","affiliation":[{"name":"University of Kentucky, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly","family":"Bridden","sequence":"additional","affiliation":[{"name":"Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia-Cara","family":"Christopher","sequence":"additional","affiliation":[{"name":"RTI International, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Clarke","sequence":"additional","affiliation":[{"name":"Substance Abuse and Mental Health Services Administration, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"David","sequence":"additional","affiliation":[{"name":"Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"D\u2019Costa","sequence":"additional","affiliation":[{"name":"RTI International, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Ewing","sequence":"additional","affiliation":[{"name":"University of Cincinnati College of Medicine, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soledad","family":"Fernandez","sequence":"additional","affiliation":[{"name":"Ohio State University Department of Biomedical Informatics and Center for Biostatistics, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Gibson","sequence":"additional","affiliation":[{"name":"Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Gilbert","sequence":"additional","affiliation":[{"name":"Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E.","family":"Hall","sequence":"additional","affiliation":[{"name":"RTI International, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hargrove","sequence":"additional","affiliation":[{"name":"University of Kentucky, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Hunt","sequence":"additional","affiliation":[{"name":"Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth N.","family":"Kinnard","sequence":"additional","affiliation":[{"name":"Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Larochelle","sequence":"additional","affiliation":[{"name":"Massachusetts Department of Public Health, Dorchester"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Macoubray","sequence":"additional","affiliation":[{"name":"RTI International, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Nigam","sequence":"additional","affiliation":[{"name":"University of Kentucky, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward V.","family":"Nunes","sequence":"additional","affiliation":[{"name":"Columbia University Irving Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie B.","family":"Oser","sequence":"additional","affiliation":[{"name":"University of Kentucky, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Pagnano","sequence":"additional","affiliation":[{"name":"Massachusetts Department of Public Health, Dorchester"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rock","sequence":"additional","affiliation":[{"name":"University of Kentucky, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Salsberry","sequence":"additional","affiliation":[{"name":"Ohio State University College of Public Health, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee","family":"Shadwick","sequence":"additional","affiliation":[{"name":"Recovery Ohio, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Stopka","sequence":"additional","affiliation":[{"name":"Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Tan","sequence":"additional","affiliation":[{"name":"RTI International, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Westgate","sequence":"additional","affiliation":[{"name":"University of Kentucky, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elwin","family":"Wu","sequence":"additional","affiliation":[{"name":"Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary A.","family":"Zarkin","sequence":"additional","affiliation":[{"name":"RTI International, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L.","family":"Walsh","sequence":"additional","affiliation":[{"name":"University of Kentucky College of Medicine, Center on Drug and Alcohol Research, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabila","family":"El-Bassel","sequence":"additional","affiliation":[{"name":"Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. John","family":"Winhusen","sequence":"additional","affiliation":[{"name":"University of Cincinnati College of Medicine, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey H.","family":"Samet","sequence":"additional","affiliation":[{"name":"Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel A.","family":"Oga","sequence":"additional","affiliation":[{"name":"RTI International, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"issue":"35","key":"zoi241150r3","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.15585\/mmwr.mm6935a1","article-title":"Vital Signs: characteristics of drug overdose deaths involving opioids and stimulants\u201424 states and the District of Columbia, January\u2013June 2019.","volume":"69","author":"O\u2019Donnell","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"zoi241150r4","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41398-019-0625-0","article-title":"The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies.","volume":"9","author":"Han","year":"2019","journal-title":"Transl Psychiatry"},{"key":"zoi241150r5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugalcdep.2016.11.033","article-title":"A review: fentanyl and non-pharmaceutical fentanyls.","volume":"171","author":"Suzuki","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"zoi241150r6","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2020.106625","article-title":"Racial\/ethnic differences in US drug overdose mortality, 2017-2018.","volume":"112","author":"Cano","year":"2021","journal-title":"Addict Behav"},{"issue":"1","key":"zoi241150r7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41380-020-00949-3","article-title":"Polysubstance use in the U.S. opioid crisis.","volume":"26","author":"Compton","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"3","key":"zoi241150r8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/ADM.0000000000000034","article-title":"A systematic review of community opioid overdose prevention and naloxone distribution programs.","volume":"8","author":"Clark","year":"2014","journal-title":"J Addict Med"},{"issue":"1","key":"zoi241150r9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40621-015-0041-8","article-title":"Effectiveness of bystander naloxone administration and overdose education programs: a meta-analysis.","volume":"2","author":"Giglio","year":"2015","journal-title":"Inj Epidemiol"},{"issue":"8","key":"zoi241150r10","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2105\/AJPH.2021.306306","article-title":"The effect of overdose education and naloxone distribution: an umbrella review of systematic reviews.","volume":"111","author":"Razaghizad","year":"2021","journal-title":"Am J Public Health"},{"issue":"1","key":"zoi241150r11","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1186\/s12889-021-10497-2","article-title":"Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review.","volume":"21","author":"Moustaqim-Barrette","year":"2021","journal-title":"BMC Public Health"},{"key":"zoi241150r12","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"issue":"3","key":"zoi241150r13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain\u2014United States, 2022.","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"key":"zoi241150r14","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108329","article-title":"Addressing opioid overdose deaths: the vision for the HEALing communities study.","volume":"217","author":"Chandler","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"zoi241150r15","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108325","article-title":"The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): evidence-based practices in the HEALing Communities Study.","volume":"217","author":"Winhusen","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"zoi241150r16","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108338","article-title":"Health communication campaigns to drive demand for evidence-based practices and reduce stigma in the HEALing communities study.","volume":"217","author":"Lefebvre","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"zoi241150r17","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108326","article-title":"Community engagement to implement evidence-based practices in the HEALing communities study.","volume":"217","author":"Sprague Martinez","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"zoi241150r18","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108331","article-title":"Community dashboards to support data-informed decision-making in the HEALing communities study.","volume":"217","author":"Wu","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"zoi241150r19","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108335","article-title":"The HEALing (Helping to End Addiction Long-term) Communities Study: protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices.","volume":"217","author":"Walsh","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"zoi241150r20","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108328","article-title":"Operationalizing and selecting outcome measures for the HEALing Communities Study.","volume":"217","author":"Slavova","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"zoi241150r21","author":"Samet","year":"2024","journal-title":"NEJM"},{"issue":"2","key":"zoi241150r27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/17407745211063479","article-title":"Marginal modeling in community randomized trials with rare events: utilization of the negative binomial regression model.","volume":"19","author":"Westgate","year":"2022","journal-title":"Clin Trials"},{"issue":"1","key":"zoi241150r28","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.0006-341X.2001.00126.x","article-title":"A covariance estimator for GEE with improved small-sample properties.","volume":"57","author":"Mancl","year":"2001","journal-title":"Biometrics"},{"issue":"456","key":"zoi241150r29","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1198\/016214501753382309","article-title":"A note on the efficiency of sandwich covariance matrix estimation.","volume":"96","author":"Kauermann","year":"2001","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"zoi241150r30","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/bimj.201600182","article-title":"Improved standard error estimator for maintaining the validity of inference in cluster randomized trials with a small number of clusters.","volume":"59","author":"Ford","year":"2017","journal-title":"Biom J"},{"issue":"1","key":"zoi241150r31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing.","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol"},{"issue":"4","key":"zoi241150r32","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis.","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Curr Opin Psychiatry"},{"issue":"1","key":"zoi241150r33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13722-022-00322-5","article-title":"The Rural Opioid Initiative Consortium description: providing evidence to understand the fourth wave of the opioid crisis.","volume":"17","author":"Jenkins","year":"2022","journal-title":"Addict Sci Clin Pract"},{"issue":"5","key":"zoi241150r34","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/add.14878","article-title":"The rise in non-fatal and fatal overdoses involving stimulants with and without opioids in the United States.","volume":"115","author":"Hoots","year":"2020","journal-title":"Addiction"},{"issue":"10","key":"zoi241150r35","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/10810730.2023.2262948","article-title":"Lessons learned from developing tailored community communication campaigns in the HEALing Communities Study.","volume":"28","author":"Stein","year":"2023","journal-title":"J Health Commun"},{"issue":"345","key":"zoi241150r36","first-page":"1","article-title":"Urban-rural differences in drug overdose death rates, by sex, age, and type of drugs involved, 2017.","author":"Hedegaard","year":"2019","journal-title":"NCHS Data Brief"},{"issue":"1","key":"zoi241150r37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nyas.14688","article-title":"Methamphetamine use in the United States: epidemiological update and implications for prevention, treatment, and harm reduction.","volume":"1508","author":"Jones","year":"2022","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"zoi241150r38","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/ADM.0000000000001132","article-title":"Widespread distribution of xylazine detected throughout the United States in healthcare patient samples.","volume":"17","author":"Holt","year":"2023","journal-title":"J Addict Med"},{"issue":"1","key":"zoi241150r39","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11524-018-00343-z","article-title":"Increased presence of fentanyl in cocaine-involved fatal overdoses: implications for prevention.","volume":"96","author":"Nolan","year":"2019","journal-title":"J Urban Health"},{"key":"zoi241150r40","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2023.111775","article-title":"Non-fentanyl new synthetic opioids\u2014an update.","volume":"349","author":"Zawilska","year":"2023","journal-title":"Forensic Sci Int"},{"issue":"26","key":"zoi241150r41","doi-asserted-by":"crossref","first-page":"721","DOI":"10.15585\/mmwr.mm7226a4","article-title":"Illicitly manufactured fentanyl-involved overdose deaths with detected xylazine\u2014United States, January 2019-June 2022.","volume":"72","author":"Kariisa","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"zoi241150r42","article-title":"Effects of the Communities that Heal (CTH) intervention on perceived opioid-related community stigma in the HEALing Communities Study: results of a multi-site, community-level, cluster-randomized trial.","volume":"32","author":"Davis","year":"2024","journal-title":"Lancet Reg Health Am"},{"key":"zoi241150r1","doi-asserted-by":"crossref","unstructured":"Spencer? MR, Mini\u00f1o? AM, Warner? M. Drug overdose deaths in the United States, 2001\u20132021. National Center for Health Statistics Data Brief No. 457. December 2022. Accessed May 29, 2024. https:\/\/stacks.cdc.gov\/view\/cdc\/122556","DOI":"10.15620\/cdc:122556"},{"key":"zoi241150r2","unstructured":"Centers for Disease Control and Prevention. Provisional data shows U.S. drug overdose deaths top 100,000 in 2022. Published May 18, 2023. Accessed February 22, 2024. https:\/\/blogs.cdc.gov\/nchs\/2023\/05\/18\/7365\/."},{"key":"zoi241150r22","unstructured":"World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 10th Revision. Published online 2016. Accessed February 22, 2024. https:\/\/icd.who.int\/browse10\/2016\/en"},{"key":"zoi241150r23","unstructured":"Centers for Disease Control and Prevention. US Census Populations With Bridged Race Categories. Updated October 28, 2022. Accessed June 20, 2023. https:\/\/www.cdc.gov\/nchs\/nvss\/bridged_race.htm"},{"key":"zoi241150r24","unstructured":"US Census Bureau. Explore Census Data. Accessed June 20, 2023. https:\/\/data.census.gov\/cedsci"},{"key":"zoi241150r25","unstructured":"Ingram? DD, Franco? SJ. 2013 NCHS Urban-Rural Classification Scheme for Counties. National Center for Health Statistics Vital Health Statistics report\u2014Series 2, No. 166. 2014. https:\/\/www.cdc.gov\/nchs\/data\/series\/sr_02\/sr02_166.pdf"},{"key":"zoi241150r26","unstructured":"Massachusetts State Office of Rural Health. Rural Definition. July 21, 2017. Accessed February 23, 2024. https:\/\/www.mass.gov\/doc\/rural-definition-detail-0\/download"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2825142\/freisthler_2024_oi_241150_1746541678.73382.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T15:00:30Z","timestamp":1746802830000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2825142"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.40006","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,21]]}}}